Here is my 2 cents on the approval. First thing I noticed it is an ELISA test (Dr Moro's recent press release about our new ELISA test is not a coincidence). Secondly, their approval bodes very well for us. Third, it is to be used with persons ALREADY DIAGNOSED with colorectal cancer. Fourth, it is to be used in conjunction with other clinical modalities that are within the standard of care.
It would appear that Recaf will be approved under the same restrictions at first, but IMO, WE will be the standard of care.